Compile Data Set for Download or QSAR
maximum 50k data
Found 122 Enz. Inhib. hit(s) with all data for entry = 5844
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97403(Orexin receptor antagonist 35 | US20130102619, 35)
Affinity DataKi:  1nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97397(Orexin receptor antagonist 29 | Orexin receptor an...)
Affinity DataKi:  1.10nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97407(Orexin receptor antagonist 2 | US20130102619, 2)
Affinity DataKi:  1.30nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97397(Orexin receptor antagonist 29 | Orexin receptor an...)
Affinity DataKi:  1.30nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97406(Orexin receptor antagonist 1 | US20130102619, 1)
Affinity DataKi:  1.60nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97400(Orexin receptor antagonist 32 | US20130102619, 32)
Affinity DataKi:  2.10nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97404(Orexin receptor antagonist 36 | US20130102619, 36)
Affinity DataKi:  2.10nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97374(Orexin receptor antagonist 4 | US20130102619, 4)
Affinity DataKi:  2.30nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97373(Orexin receptor antagonist 5 | US20130102619, 5)
Affinity DataKi:  3nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97390(Orexin receptor antagonist 22 | US20130102619, 22)
Affinity DataKi:  3.40nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97402(Orexin receptor antagonist 34 | US20130102619, 34)
Affinity DataKi:  3.5nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97377(Orexin receptor antagonist 8 | US20130102619, 8)
Affinity DataKi:  3.5nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97378(Orexin receptor antagonist 9 | US20130102619, 9)
Affinity DataKi:  3.70nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97408(Orexin receptor antagonist 3 | US20130102619, 3)
Affinity DataKi:  4.5nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97375(Orexin receptor antagonist 6 | US20130102619, 6)
Affinity DataKi:  5.5nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97379(Orexin receptor antagonist 10 | US20130102619, 10)
Affinity DataKi:  5.90nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97399(Orexin receptor antagonist 31 | US20130102619, 31)
Affinity DataKi:  5.90nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97384(Orexin receptor antagonist 15 | US20130102619, 15)
Affinity DataKi:  9.10nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97388(Orexin receptor antagonist 20 | US20130102619, 20)
Affinity DataKi:  11.5nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97401(Orexin receptor antagonist 33 | US20130102619, 33)
Affinity DataKi:  12.4nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97385(Orexin receptor antagonist 17 | US20130102619, 17)
Affinity DataKi:  15nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97383(Orexin receptor antagonist 14 | US20130102619, 14)
Affinity DataKi:  15nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97391(Orexin receptor antagonist 23 | US20130102619, 23)
Affinity DataKi:  35nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97376(Orexin receptor antagonist 16 | US20130102619, 16)
Affinity DataKi:  57nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97392(Orexin receptor antagonist 24 | US20130102619, 24)
Affinity DataKi:  79nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97380(Orexin receptor antagonist 11 | US20130102619, 11)
Affinity DataKi:  94nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97386(Orexin receptor antagonist 18 | US20130102619, 18)
Affinity DataKi:  134nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97382(Orexin receptor antagonist 13 | US20130102619, 13)
Affinity DataKi:  137nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97381(Orexin receptor antagonist 12 | US20130102619, 12)
Affinity DataKi:  151nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97394(Orexin receptor antagonist 26 | US20130102619, 26)
Affinity DataKi:  162nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97384(Orexin receptor antagonist 15 | US20130102619, 15)
Affinity DataKi:  265nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97396(Orexin receptor antagonist 28 | US20130102619, 28)
Affinity DataKi:  618nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97403(Orexin receptor antagonist 35 | US20130102619, 35)
Affinity DataKi:  658nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97373(Orexin receptor antagonist 5 | US20130102619, 5)
Affinity DataKi:  669nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97407(Orexin receptor antagonist 2 | US20130102619, 2)
Affinity DataKi:  761nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97406(Orexin receptor antagonist 1 | US20130102619, 1)
Affinity DataKi:  813nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97402(Orexin receptor antagonist 34 | US20130102619, 34)
Affinity DataKi:  868nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97404(Orexin receptor antagonist 36 | US20130102619, 36)
Affinity DataKi:  930nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97374(Orexin receptor antagonist 4 | US20130102619, 4)
Affinity DataKi:  932nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97397(Orexin receptor antagonist 29 | Orexin receptor an...)
Affinity DataKi:  997nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97395(Orexin receptor antagonist 27 | US20130102619, 27)
Affinity DataKi:  1.04E+3nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97397(Orexin receptor antagonist 29 | Orexin receptor an...)
Affinity DataKi:  1.11E+3nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97378(Orexin receptor antagonist 9 | US20130102619, 9)
Affinity DataKi:  1.25E+3nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97400(Orexin receptor antagonist 32 | US20130102619, 32)
Affinity DataKi:  1.25E+3nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97386(Orexin receptor antagonist 18 | US20130102619, 18)
Affinity DataKi:  1.29E+3nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97387(Orexin receptor antagonist 19 | US20130102619, 19)
Affinity DataKi:  1.36E+3nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97408(Orexin receptor antagonist 3 | US20130102619, 3)
Affinity DataKi:  1.66E+3nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97401(Orexin receptor antagonist 33 | US20130102619, 33)
Affinity DataKi:  1.69E+3nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97390(Orexin receptor antagonist 22 | US20130102619, 22)
Affinity DataKi:  1.79E+3nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
TBA

US Patent
LigandPNGBDBM97375(Orexin receptor antagonist 6 | US20130102619, 6)
Affinity DataKi:  1.90E+3nMAssay Description:The inhibition constant (ki) is determined using a radioligand assay.More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 122 total ) | Next | Last >>
Jump to: